Antitrust IntelligenceAntitrust IntelligenceAntitrust Intelligence
Prices
Notification
Font ResizerAa
  • For Lawyers
  • For Investors
  • News
  • What We Offer
Reading: Hungarian Competition Authority Fines Medical Device Companies for Cartelization
Font ResizerAa
Antitrust IntelligenceAntitrust Intelligence
Search
  • For Lawyers
  • For Investors
  • News
  • What We Offer
Have an existing account? Sign In
Follow US
News

Hungarian Competition Authority Fines Medical Device Companies for Cartelization

Editorial
Last updated: August 4, 2025 10:21 am
Editorial
Published August 4, 2025
Share
Photo by Marta Branco: https://www.pexels.com/photo/essential-tools-for-managing-heart-health-condition-32210639/

The Hungarian Competition Authority (GVH) has imposed fines totaling HUF 547.8 million (€1.38 million) on three medical device companies for participating in a cartel involving diagnostic imaging equipment. The decision follows a partially repeated procedure ordered by Hungary’s Curia, which confirmed the existence of the cartel but required a recalculation of the penalties.

The sanctioned companies — GE Hungary Ipari és Kereskedelmi Kft., Premier G. Med Egészségügyi Kft., and Medirex Zrt. — had originally appealed the GVH’s 2020 ruling that imposed more than HUF 1.6 billion in fines on ten companies for collusion in public procurement procedures. While the Curia upheld the finding of prohibited market division, it instructed the GVH to reconsider the fines for these three companies.

In the repeated proceedings, the firms acknowledged the facts established by the authority, waived their right to further appeal, and cooperated fully, which resulted in significant reductions in their fines. The Competition Council allocated the penalties as follows:

  • GE Hungary: HUF 238.8 million (€600,000)
  • Premier G. Med: HUF 202.3 million (€510,000)
  • Medirex Zrt.: HUF 106.7 million (€270,000)

Combined with fines already paid by other participants in the original case — more than HUF 861 million — the GVH’s enforcement has generated a total of over HUF 1.4 billion (€3.56 million) for the central budget.

The GVH highlighted that this case demonstrates the benefits of cooperation with the national competition authority. Under Hungary’s Competition Act, companies that voluntarily admit wrongdoing, provide evidence, or cooperate in investigations may see their fines substantially reduced or even avoided entirely.

Launched in early 2020, the GVH’s probe revealed widespread collusion among companies supplying diagnostic imaging devices to hospitals and clinics, distorting competition in public procurement markets. The authority reiterated that cartel conduct not only undermines fair competition but also places a heavy burden on public healthcare budgets.

You Might Also Like

£5 Billion Lawsuit Hits Google Over UK Search Ad Monopoly

EU Launches Legal Action Against Spain Over Bank Merger Rules

CCP and Punjab Food Authority Collaborate to Protect Consumers and Ensure Fair Competition

CADE Modifies Interim Measure Against CA Investment in Eldorado

Seven Housebuilders agreed to pay £100 Million to Settle Cartel Probe

TAGGED:GVHHungarian Competition Authority Fines Medical Device Companies for CartelizationHungary

Weekly Newsletter

Insights you can turn into money or clients
Investors

Microsoft, Google & Amazon Soar in the Cloud While Watchdogs Hit Snooze

Editorial
Editorial
August 3, 2025
Telefónica’s M&A Ambitions Meet Reality Check After Q2 Results
Antitrust Intelligence

About Us

We identify and quantify regulatory risks so you can take better decisions
Menu
  • Lawyers
  • Investors
  • News
  • My Bookmarks
  • About Us
  • Contact
Legals
  • Cookie Policy
  • Terms & Conditions
  • Privacy Policy

Subscribe Us

Subscribe to our newsletter to get weekly ideas to make money and get new clients!

© 2025 Antitrust Intelligence. All Rights Reserved. - Web design Málaga by Seb creativos
Antitrust Intelligence
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
Antitrust & Financial Markets? Download Your Free Guide NOW
Five tips to find unique regulatory intelligence
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?